KREBS BIOCHEMICALS & IND
KREBSBIO · NSE
56.60
-1.33 (-2.30%)
as of 30 Oct 2026 close
Open
56.60
High
58.49
Low
56.33
Prev close
57.93
52w high
76.85
05 Dec 2025
52w low
38.33
30 Mar 2026
VWAP
56.82
Delivery %
60.1%
of volume
Volume 5,397 · turnover ₹3.07 L · NSE bhavcopy (official close) · history since 27 Oct 2016
- Market cap
- ₹122 cr
- ISIN
- INE268B01013
- Series
- EQ
- Listed on NSE
- 03 Jan 1996
- Face value
- ₹10
- F&O
- No
Earlier name: Krebs Biochemicals Limited (until 27 Oct 2016).
Source: NSE equity master · as of 31 Oct 2026 · market cap = shares (30 Sept 2026 filing) × close
Market cap
₹122 cr
P/B
—
ROE (TTM)
—
Debt / equity
—
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
—
Net profit TTM
—
Net margin TTM
—
EV / EBITDA
—
Interest cover
—
Revenue growth
—
latest quarter YoY
Profit growth
—
latest quarter YoY
Dividend yield
—
last 12 months
Standalone · last four quarters to 2026-09-30 · balance sheet 2026-09-30 · tap a tile for the formula
Daily · NSE EOD
Moving averages & momentum · as of 30 Oct 2026 close
| SMA 20 | 58.94 |
| SMA 50 | 57.41 |
| SMA 200 | 57.93 |
| RSI 14 | 47.5 |
| ATR 14 | 4.90 |
How these are computed
SMA n = mean of last n daily closes. RSI 14 = Wilder smoothing of average gains/losses over 14 days. ATR 14 = Wilder average of true range (max of high−low, |high−prev close|, |low−prev close|). All from NSE end-of-day candles; nothing intraday.
52-week position · as of 30 Oct 2026 close
38.33 30 Mar 202647% of range76.85 05 Dec 2025
Returns · close to close
1w
+9.16%
1m
+0.32%
3m
+5.09%
6m
-5.67%
1y
-18.20%
Corporate actions · latest 1 · NSE
| 31 Jan 2019 | Rights |
Ex-dates and subjects from NSE's corporate-actions feed; price-adjustment factors checked against the exchange's own prices. Charts use the adjusted series by default.